Skip to content
How Pharmacogenomics Testing Reduces Polypharmacy Risks with Dr. Houda Hachad Aranscia episode artwork

Jun 23, 2026 21 min

How Pharmacogenomics Testing Reduces Polypharmacy Risks with Dr. Houda Hachad Aranscia

from Empowered Patient Podcast Hosted by Karen Jagoda

Dr. Houda Hachad, Vice President of Clinical Operations at Aranscia, highlights the importance of regular medication reviews in an age of growing polypharmacy and advancements in the use of pharmacogenomics to identify potential risks. The key goal is to use the minimal effective dose of a medication and determine which drugs are most effective for treating identified conditions without causing unintended side effects. Adopting a preemptive pharmacogenomic testing approach for patients taking more than 5 drugs is noted as a way to reduce hospital readmissions, emergency room visits, and adverse drug events. Houda explains, "So polypharmacy is becoming more and more common. I think the data shows that up to 40% of adults now take a lot of medications. And polypharmacy is typically defined as the regular use of five medications or more. But in some settings, we're seeing what we call excessive polypharmacy, which is using nine or more." "So there are multiple patient cohorts, as you can imagine, that take these medications, definitely patients in hospital settings, older patients, patients that suffer from behavioral health issues, and any chronic conditions, patients with diabetes, hypertension, and obesity are going to be your typical polypharmacy patients. So our tools, which span genetic testing, medication reviews, and the use of various patient information to provide precision care, allow us to simplify and help doctors mitigate the risks associated with polypharmacy." "Each time you add a medication to a patient, you're increasing the risk of having these adverse drug events. We have tools that can reduce the risk of polypharmacy, including pharmacogenomics." #Aranscia #Polypharmacy, #DrugGeneInteractions #dpydTesting #MedicationSafety #Pharmacogenomics aranscia.com Download the transcript here

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

How Pharmacogenomics Testing Reduces Polypharmacy Risks with Dr. Houda Hachad Aranscia

0:00 21:41

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Empowered Patient Podcast?

This episode is 21 minutes long.

When was this Empowered Patient Podcast episode published?

This episode was published on June 23, 2026.

Can I download this Empowered Patient Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.